CD55 anticorps (Biotin)

N° du produit ABIN3071840

Cet anticorps Souris Monoclonal détecte spécifiquement CD55 dans FACS. Il présente une réactivité envers Humain.

Aperçu rapide pour CD55 anticorps (Biotin) (ABIN3071840)

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD55 est conjugé à/à la Biotin

Application: Flow Cytometry (FACS)

Classe de qualité: GMP Grade

Clone: F4-29D9

Détail du produit anti-CD55 anticorps (Biotin)

Fonction: CD55 Biotin Antibody

Attributs du produit: The clone F4-29D9 binds with a single chain 70 kDa glycoprotein and identified as CD55 (also known as decay accelerating factor, DAF). CD55 is widely expressed on cells throughout the body including leukocytes, erythrocytes, epithelium, endothelium, and fibroblasts. It is a Glycosyl phosphatidylinositol anchored (GPI-anchored) protein and inhibits autologous complement cascade activation. CD55 also serves as receptor for CD97, echovirus and Coxsackie B virus. Anticd55 is a useful marker for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH).

Purification: Purified

Pureté: >95 %

Immunogène: Human umbilical vein endothelial cells

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS pH 7.2, 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: 2-8°C, Conjugated antibodies should never be frozen.

Détails sur CD55

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Autre désignation: CD55

NCBI Accession: NP_000565, NM_000574, NP_001108224, NM_001114752, NP_001287832, NM_001300903, NP_001287833

UniProt: P08174

Pathways: Système du Complément, Regulation of Leukocyte Mediated Immunity